Immucell (ICCC) EPS (Diluted) Growth (1y) (2011 - 2026)
Powered by 
Analysis
Immucell (ICCC) EPS (Diluted) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 17.55% |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | 1.28% |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 385.28% |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 72.87% |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 259.27% |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | -3.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 259.27% |
| Dec 31, 2025 | -343.20% |
| Sep 30, 2025 | 82.02% |
| Jun 30, 2025 | 128.34% |
| Mar 31, 2025 | 385.21% |
| Dec 31, 2024 | 1,109.68% |
| Sep 30, 2024 | 29.17% |
| Jun 30, 2024 | -10.11% |
| Mar 31, 2024 | 81.10% |
| Dec 31, 2023 | 106.72% |
| Sep 30, 2023 | -43.49% |
| Jun 30, 2023 | -43.97% |
| Mar 31, 2023 | -416.42% |
| Dec 31, 2022 | -1,240.56% |
| Sep 30, 2022 | -547.53% |
| Jun 30, 2022 | -780.37% |
| Mar 31, 2022 | 254.50% |
| Dec 31, 2021 | 344.05% |
| Sep 30, 2021 | 142.21% |
| Jun 30, 2021 | 117.13% |